KALV vs GILD: Which Stock is Better?
Side-by-side comparison of Kalvista Pharmaceuticals Inc and Gilead Sciences Inc in 2026
KALV
Kalvista Pharmaceuticals Inc
$20.48
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | KALV | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.00B | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.3% | 0.0% | KALV |
| Gross Margin | 25.7% | 78.8% | GILD |
Analyze KALV
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KALV or GILD a better investment?
Comparing KALV and GILD: Kalvista Pharmaceuticals Inc has a market cap of $1.00B while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KALV and GILD?
KALV (Kalvista Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KALV or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KALV or GILD?
KALV has higher revenue growth at 0.3% vs 0.0% for GILD.
Which company is more profitable: KALV or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 25.7% for KALV.
Which is the larger company: KALV or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $1.00B for KALV.
Should I buy KALV or GILD in 2026?
Both KALV and GILD have investment merit. KALV trades at $20.48 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KALV and GILD stock?
Key differences: Market Cap ($1.00B vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.3% vs 0.0%), Gross Margin (25.7% vs 78.8%).